Improving the benefit/risk ratio.
Wessler
S
S
Department of Medicine, New York University School of Medicine, New York.
D003930:Diabetic Retinopathy / Q000150:complications; D004032:Diet; D005260:Female; D006493:Heparin / Q000008:administration & dosage; D006801:Humans; D007774:Lactation; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage; D011183:Postoperative Complications / Q000517:prevention & control; D011247:Pregnancy; D012307:Risk Factors; D013723:Teratogens; D014859:Warfarin / Q000627:therapeutic use*
D010975:Platelet Aggregation Inhibitors; D013723:Teratogens; D014859:Warfarin; D006493:Heparin